Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Roland E. Kontermann, Guy Ungerechts & Dirk M. Nettelbeck. (2021) Viro-antibody therapy: engineering oncolytic viruses for genetic delivery of diverse antibody-based biotherapeutics. mAbs 13:1.
Read now
Read now
Michael H Kershaw, Christel Devaud, Liza B John, Jennifer A Westwood & Phillip K Darcy. (2013) Enhancing immunotherapy using chemotherapy and radiation to modify the tumor microenvironment. OncoImmunology 2:9.
Read now
Read now
Articles from other publishers (15)
Gonzalo RodríguezMarcelo FernándezMirel CabreraMarcos TassanoPablo CabralMarcos CoutoHugo Cerecetto & María Fernanda García.. (2023)
Looking for New [1,2,4,5]Tetrazines to Produce
99m
Tc‐Labelled Derivatives, with a Suitable Lipophilicity Balance for Use in Bioorthogonal Reactions
. ChemistrySelect 8:41.
Crossref
Crossref
María Fernanda García, Fabio Gallazzi, Mara de Souza Junqueira, Marcelo Fernández, Ximena Camacho, Janio da Silva Mororó, Daniele Faria, Camila de Godoi Carneiro, Marcos Couto, Federico Carrión, Otto Pritsch, Roger Chammas, Thomas Quinn, Pablo Cabral & Hugo Cerecetto. (2018)
Synthesis of hydrophilic HYNIC-[1,2,4,5]tetrazine conjugates and their use in antibody pretargeting with
99m
Tc
. Organic & Biomolecular Chemistry 16:29, pages 5275-5285.
Crossref
Crossref
Malay Patra, Kristof Zarschler, Hans-Jürgen Pietzsch, Holger Stephan & Gilles Gasser. (2016) New insights into the pretargeting approach to image and treat tumours. Chemical Society Reviews 45:23, pages 6415-6431.
Crossref
Crossref
Matthew S.R. Abbott, Chelsea M. Brain, Adam P. Harvey, Michelle I. Morrison & Gustavo Valente Perez. (2015) Liquid culture of microalgae in a photobioreactor (PBR) based on oscillatory baffled reactor (OBR) technology – A feasibility study. Chemical Engineering Science 138, pages 315-323.
Crossref
Crossref
Oluwatosin O. Dada, Nomalie Jaya, John Valliere-Douglass & Oscar Salas-Solano. (2015) Characterization of acidic and basic variants of IgG1 therapeutic monoclonal antibodies based on non-denaturing IEF fractionation. ELECTROPHORESIS 36:21-22, pages 2695-2702.
Crossref
Crossref
Anna Leonidova, Christian Foerster, Kristof Zarschler, Maik Schubert, Hans-Jürgen Pietzsch, Jörg Steinbach, Ralf Bergmann, Nils Metzler-Nolte, Holger Stephan & Gilles Gasser. (2015)
In vivo
demonstration of an active tumor pretargeting approach with peptide nucleic acid bioconjugates as complementary system
. Chemical Science 6:10, pages 5601-5616.
Crossref
Crossref
Roy Noy, Maya Haus-Cohen, Kfir Oved, Tali Voloshin & Yoram Reiter. (2015) Recruitment of Oligoclonal Viral-Specific T cells to Kill Human Tumor Cells Using Single-Chain Antibody–Peptide–HLA Fusion Molecules. Molecular Cancer Therapeutics 14:6, pages 1327-1335.
Crossref
Crossref
S M Deyev, E N Lebedenko, L E Petrovskaya, D A Dolgikh, A G Gabibov & M P Kirpichnikov. (2015) Man-made antibodies and immunoconjugates with desired properties: function optimization using structural engineering. Russian Chemical Reviews 84:1, pages 1-26.
Crossref
Crossref
Floor C. J. van de Watering, Mark Rijpkema, Marc Robillard, Wim J. G. Oyen & Otto C. Boerman. (2014) Pretargeted Imaging and Radioimmunotherapy of Cancer Using Antibodies and Bioorthogonal Chemistry. Frontiers in Medicine 1.
Crossref
Crossref
Qichun Wei, Jing Xu, Li Shen, Xianhua Fu, Bicheng Zhang, Xiaofeng Zhou & Jorgen Carlsson. (2014) HER2 expression in primary gastric cancers and paired synchronous lymph node and liver metastases. A possible road to target HER2 with radionuclides. Tumor Biology 35:7, pages 6319-6326.
Crossref
Crossref
Zbynek Novy, Alice Laznickova, Jana Mandikova, Pavel Barta, Milan Laznicek & Frantisek Trejtnar. (2014)
The effect of chelator type on
in vitro
receptor binding and stability in
177
Lu-labeled cetuximab and panitumumab
. Journal of Labelled Compounds and Radiopharmaceuticals 57:7, pages 448-452.
Crossref
Crossref
Aditi M. Jhaveri & Vladimir P. Torchilin. (2014) Multifunctional polymeric micelles for delivery of drugs and siRNA. Frontiers in Pharmacology 5.
Crossref
Crossref
Monika E. Freiser, Paolo Serafini & Donald T. Weed. (2013) The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities. Immunologic Research 57:1-3, pages 52-69.
Crossref
Crossref
Miller Tran, Ryan E. Henry, David Siefker, Christina Van, Greg Newkirk, Julie Kim, Jack Bui & Stephen P. Mayfield. (2013) Production of anti-cancer immunotoxins in algae: Ribosome inactivating proteins as fusion partners. Biotechnology and Bioengineering 110:11, pages 2826-2835.
Crossref
Crossref
Hendrik Fuchs, Christopher Bachran & David Flavell. (2013) Diving through Membranes: Molecular Cunning to Enforce the Endosomal Escape of Antibody-Targeted Anti-Tumor Toxins. Antibodies 2:4, pages 209-235.
Crossref
Crossref